Stay updated on Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial

Sign up to get notified when there's something new on the Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T13:21:43.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A notice appears at the top of the page announcing NIH website updates and explaining that some NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T14:32:28.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 while the page remains a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-19T14:27:38.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1. The page remains a 403 Forbidden error page.
    Difference
    0.2%
    Check dated 2026-10-12T14:32:12.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details. Access to the record is blocked.
    Difference
    18%
    Check dated 2026-09-21T22:14:11.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6, indicating a recent update to the study page's content or layout. This reflects a minor change to the page's metadata.
    Difference
    0.1%
    Check dated 2026-08-31T18:30:10.000Z thumbnail image

Stay in the know with updates to Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial page.